rs33935373

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001372106.1(DNAH10):​c.6311C>T​(p.Thr2104Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0359 in 1,603,722 control chromosomes in the GnomAD database, including 1,220 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 61 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1159 hom. )

Consequence

DNAH10
NM_001372106.1 missense

Scores

5
3
7

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 7.89

Publications

10 publications found
Variant links:
Genes affected
DNAH10 (HGNC:2941): (dynein axonemal heavy chain 10) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. The axonemal dyneins, found in cilia and flagella, are components of the outer and inner dynein arms attached to the peripheral microtubule doublets. DNAH10 is an inner arm dynein heavy chain (Maiti et al., 2000 [PubMed 11175280]).[supplied by OMIM, Mar 2008]
DNAH10 Gene-Disease associations (from GenCC):
  • spermatogenic failure 56
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008422822).
BP6
Variant 12-123853225-C-T is Benign according to our data. Variant chr12-123853225-C-T is described in ClinVar as Benign. ClinVar VariationId is 402617.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0244 (3704/151884) while in subpopulation NFE AF = 0.0385 (2615/67984). AF 95% confidence interval is 0.0372. There are 61 homozygotes in GnomAd4. There are 1828 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 61 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH10NM_001372106.1 linkc.6311C>T p.Thr2104Met missense_variant Exon 36 of 79 ENST00000673944.1 NP_001359035.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH10ENST00000673944.1 linkc.6311C>T p.Thr2104Met missense_variant Exon 36 of 79 NM_001372106.1 ENSP00000501095.1 A0A669KB38
DNAH10ENST00000409039.8 linkc.6140C>T p.Thr2047Met missense_variant Exon 35 of 78 5 ENSP00000386770.4 A0A1C7CYW8
DNAH10ENST00000638045.1 linkc.5957C>T p.Thr1986Met missense_variant Exon 35 of 78 5 ENSP00000489675.1 Q8IVF4-1
DNAH10ENST00000497783.3 linkn.1499C>T non_coding_transcript_exon_variant Exon 9 of 21 2 ENSP00000444761.2 F5H515

Frequencies

GnomAD3 genomes
AF:
0.0244
AC:
3706
AN:
151766
Hom.:
61
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00686
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00932
Gnomad ASJ
AF:
0.00605
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0341
Gnomad FIN
AF:
0.0396
Gnomad MID
AF:
0.0222
Gnomad NFE
AF:
0.0385
Gnomad OTH
AF:
0.0211
GnomAD2 exomes
AF:
0.0281
AC:
6706
AN:
238310
AF XY:
0.0298
show subpopulations
Gnomad AFR exome
AF:
0.00515
Gnomad AMR exome
AF:
0.00989
Gnomad ASJ exome
AF:
0.00751
Gnomad EAS exome
AF:
0.000287
Gnomad FIN exome
AF:
0.0374
Gnomad NFE exome
AF:
0.0395
Gnomad OTH exome
AF:
0.0280
GnomAD4 exome
AF:
0.0372
AC:
53941
AN:
1451838
Hom.:
1159
Cov.:
32
AF XY:
0.0370
AC XY:
26705
AN XY:
721618
show subpopulations
African (AFR)
AF:
0.00551
AC:
183
AN:
33208
American (AMR)
AF:
0.0104
AC:
450
AN:
43276
Ashkenazi Jewish (ASJ)
AF:
0.00790
AC:
204
AN:
25814
East Asian (EAS)
AF:
0.000380
AC:
15
AN:
39506
South Asian (SAS)
AF:
0.0357
AC:
3021
AN:
84556
European-Finnish (FIN)
AF:
0.0371
AC:
1962
AN:
52940
Middle Eastern (MID)
AF:
0.0162
AC:
93
AN:
5736
European-Non Finnish (NFE)
AF:
0.0417
AC:
46197
AN:
1106828
Other (OTH)
AF:
0.0303
AC:
1816
AN:
59974
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.464
Heterozygous variant carriers
0
2492
4984
7476
9968
12460
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1684
3368
5052
6736
8420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0244
AC:
3704
AN:
151884
Hom.:
61
Cov.:
32
AF XY:
0.0246
AC XY:
1828
AN XY:
74178
show subpopulations
African (AFR)
AF:
0.00684
AC:
283
AN:
41384
American (AMR)
AF:
0.00931
AC:
142
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.00605
AC:
21
AN:
3470
East Asian (EAS)
AF:
0.000194
AC:
1
AN:
5164
South Asian (SAS)
AF:
0.0341
AC:
164
AN:
4806
European-Finnish (FIN)
AF:
0.0396
AC:
416
AN:
10502
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.0385
AC:
2615
AN:
67984
Other (OTH)
AF:
0.0209
AC:
44
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
190
380
571
761
951
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
48
96
144
192
240
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0341
Hom.:
316
Bravo
AF:
0.0208
TwinsUK
AF:
0.0405
AC:
150
ALSPAC
AF:
0.0381
AC:
147
ESP6500AA
AF:
0.00585
AC:
22
ESP6500EA
AF:
0.0398
AC:
326
ExAC
AF:
0.0292
AC:
3532
Asia WGS
AF:
0.0200
AC:
69
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.13
CADD
Pathogenic
27
DANN
Uncertain
1.0
DEOGEN2
Benign
0.032
.;T
Eigen
Pathogenic
0.80
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
0.99
D;D
MetaRNN
Benign
0.0084
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Pathogenic
3.4
.;M
PhyloP100
7.9
PrimateAI
Uncertain
0.79
T
REVEL
Uncertain
0.30
Polyphen
1.0
.;D
MPC
0.65
ClinPred
0.053
T
GERP RS
5.7
Varity_R
0.69
gMVP
0.61
Mutation Taster
=38/62
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs33935373; hg19: chr12-124337772; API